v3.26.1
CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($)
$ in Thousands
6 Months Ended
Jun. 30, 2026
Jun. 30, 2025
Cash flows from operating activities:    
Net (loss) income $ (150,876) $ 124,727
Adjustments to reconcile net (loss) income to net cash used in operating activities:    
Depreciation and amortization 15,203 15,044
Equity in loss (income) of unconsolidated entities, net 112 (966)
Amortization of stock-based compensation 4,989 16,159
Settlement of previously recognized stock-based compensation (9,665) 0
Charges for impairments and lot option abandonments 20,802 14,169
Fair value adjustment on mortgage loans held for sale 825 215
Returns on investments in unconsolidated entities, net 0 966
Changes in assets and liabilities:    
Real estate inventories (286,066) (159,656)
Mortgage loans held for sale 10,808 9,924
Receivables (28,264) (54,103)
Other assets (29,762) (24,172)
Accounts payable 38,154 13,352
Accrued expenses and other liabilities (3,200) (61,075)
Net cash used in operating activities (416,940) (105,416)
Cash flows from investing activities:    
Purchases of property and equipment (13,643) (18,296)
Investments in unconsolidated entities (68,380) (32,483)
Distributions from unconsolidated entities 14,700 11,230
Net cash used in investing activities (67,323) (39,549)
Cash flows from financing activities:    
Borrowings from loans payable 0 1,600
Repayment of loans payable and senior notes (5,868) (9,649)
Debt issuance costs 0 (4,246)
Borrowings on mortgage repurchase facilities 611,264 697,084
Repayments on mortgage repurchase facilities (624,375) (702,160)
Contributions from noncontrolling interests 79 0
Tax withholding paid on behalf of employees for stock-based awards (17,566) (9,957)
Share repurchases, excluding excise tax 0 (175,110)
Net cash used in financing activities (36,466) (202,438)
Net decrease in cash and cash equivalents (520,729) (347,403)
Cash and cash equivalents–beginning of period 982,814 970,045
Cash and cash equivalents–end of period $ 462,085 $ 622,642